LifeMD, Inc. (LFMD)
Automate Your Wheel Strategy on LFMD
With Tiblio's Option Bot, you can configure your own wheel strategy including LFMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol LFMD
- Rev/Share 5.1208
- Book/Share -0.0091
- PB -223.7613
- Debt/Equity -10.7779
- CurrentRatio 0.8206
- ROIC 0.004
- MktCap 549007008.0
- FreeCF/Share 0.0734
- PFCF 173.4057
- PE -45.2911
- Debt/Assets 0.3409
- DivYield 0
- ROE 2.3313
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | LFMD | Lake Street | -- | Buy | -- | $12 | Dec. 10, 2024 |
| Initiation | LFMD | Mizuho | -- | Neutral | -- | $7 | Dec. 4, 2024 |
| Resumed | LFMD | B. Riley Securities | -- | Buy | -- | $11 | Aug. 23, 2024 |
News
LifeMD: Growth, Growth, And More Growth
Published: June 04, 2025 by: Seeking Alpha
Sentiment: Positive
LifeMD is experiencing a major growth inflection, with record Q1 revenue, first-ever GAAP profitability, and strong subscriber and margin gains. Multiple growth drivers - including GLP-1 programs, Medicare expansion, AI automation, and a women's health acquisition - support a robust multi-year growth outlook. Valuation is high on earnings metrics but discounted on sales multiples. Significant upside exists if LifeMD sustains revenue growth and achieves positive EPS.
Read More
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter Bundled Offer Includes Wegovy® at $199 and LifeMD's Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month Thereafter
Read More
LifeMD, Inc. (LFMD) Q1 2025 Earnings Call Transcript
Published: May 06, 2025 by: Seeking Alpha
Sentiment: Neutral
LifeMD, Inc. (NASDAQ:LFMD ) Q1 2025 Earnings Conference Call May 6, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman and CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG Sarah James - Cantor Fitzgerald Steve Dechert - KeyBanc Steven Valiquette - Mizuho Securities Yi Chen - H.C. Wainwright Anderson Schock - B.
Read More
LifeMD, Inc. (LFMD) Q1 Earnings and Revenues Top Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
LifeMD, Inc. (LFMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.04 per share. This compares to loss of $0.19 per share a year ago.
Read More
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
Published: April 29, 2025 by: The Motley Fool
Sentiment: Positive
Shares of Hims & Hers Health (HIMS 25.46%) and LifeMD (LFMD 35.41%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m.
Read More
LifeMD Acquires Women's Health Provider Optimal Human Health MD to Accelerate Entry into the Women's Health Market
Published: April 28, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the acquisition of key assets from Optimal Human Health MD (“Optimal”), a nationwide women's health virtual care provider. This strategic acquisition marks LifeMD's official entry into the women's health market and establishes a scalable clinical foundation for a comprehensive virtual health program under the LifeMD brand, focused on hormone health, bone density, metabolism, and long-term wellness.
Read More
About LifeMD, Inc. (LFMD)
- IPO Date 2008-01-29
- Website https://www.lifemd.com
- Industry Medical - Pharmaceuticals
- CEO Mr. Justin Schreiber
- Employees 304